Sim&Cure, leading medtech startup proving unique digital solutions to secure neurovascular treatment of cerebral aneurysm, announces a €3M funding round led by Elaia with IT Translation.
Founded in 2014 by Mathieu Sanchez (Previous Philips Healthcare R&D Engineer, PhD in biomechanics) and Vincent Costalat (MD, PhD, head of neuroradiology department at CHU Montpellier), Sim&Cure is a digital startup focused on improving neurovascular treatments of cerebral aneurysm with a proprietary software suite that has already been used to treat more than 1,500 patients in 250 hospitals.